These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8074827)

  • 1. In vitro urokinase type plasminogen activator levels and total plasminogen activator activity in squamous cell carcinomas of the head and neck.
    Petruzzelli GJ; Snyderman CH; Johnson JT
    Arch Otolaryngol Head Neck Surg; 1994 Sep; 120(9):989-92. PubMed ID: 8074827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck.
    Yasuda T; Sakata Y; Kitamura K; Morita M; Ishida T
    Head Neck; 1997 Oct; 19(7):611-6. PubMed ID: 9323150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of plasminogen activator of the head and neck tumor tissue].
    Ji X; Nong H; Huang G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase receptor up-regulation in head and neck squamous cell carcinoma.
    Schmidt M; Schler G; Gruensfelder P; Müller J; Hoppe F
    Head Neck; 2000 Aug; 22(5):498-504. PubMed ID: 10897110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and secretion of plasminogen activators and plasminogen activator inhibitors in cell lines of different groups of human lung tumors.
    Heidtmann HH; Hofmann M; Jacob E; Erbil C; Havemann K; Schwartz-Albiez R
    Cancer Res; 1989 Dec; 49(24 Pt 1):6960-5. PubMed ID: 2555056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistological study of fibrinolytic factors of head and neck squamous cell carcinomas].
    Itaya T; Motai H; Suzuki K; Baba S
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Feb; 98(2):197-202. PubMed ID: 7707177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
    Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
    Clayman G; Wang SW; Nicolson GL; el-Naggar A; Mazar A; Henkin J; Blasi F; Goepfert H; Boyd DD
    Int J Cancer; 1993 Apr; 54(1):73-80. PubMed ID: 8386710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.
    Boxman IL; Quax PH; Löwik CW; Papapoulos SE; Verheijen J; Ponec M
    J Invest Dermatol; 1995 Mar; 104(3):374-8. PubMed ID: 7861005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urokinase synthesis and binding by glomerular epithelial cells in culture.
    Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
    Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients.
    Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
    Eur J Cancer; 1998 Jul; 34(8):1193-7. PubMed ID: 9849478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas.
    Sappino AP; Busso N; Belin D; Vassalli JD
    Cancer Res; 1987 Aug; 47(15):4043-6. PubMed ID: 2440556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1.
    Schatz F; Aigner S; Papp C; Toth-Pal E; Hausknecht V; Lockwood CJ
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2504-10. PubMed ID: 7629251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface.
    Huarte J; Belin D; Bosco D; Sappino AP; Vassalli JD
    J Cell Biol; 1987 May; 104(5):1281-9. PubMed ID: 3106363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular distribution and clinical value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma.
    Shiomi H; Eguchi Y; Tani T; Kodama M; Hattori T
    Am J Pathol; 2000 Feb; 156(2):567-75. PubMed ID: 10666386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
    Jankun J; Maher VM; McCormick JJ
    Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase-type plasminogen activator in carcinomatous pleural fluid.
    Ishikawa H; Satoh H; Hasegawa S; Yazawa T; Naito T; Yamashita YT; Ohtsuka M; Ogata T; Kamma H
    Eur Respir J; 1997 Jul; 10(7):1566-71. PubMed ID: 9230248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by epidermal growth factor of human squamous cell carcinoma plasminogen activator-mediated proteolysis of extracellular matrix.
    Niedbala MJ; Sartorelli AC
    Cancer Res; 1989 Jun; 49(12):3302-9. PubMed ID: 2497975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-type plasminogen activator expression and proliferation stimulation in head and neck squamous cell carcinoma in vitro and in situ.
    Schmidt M; Grünsfelder P
    Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):679-82. PubMed ID: 11405867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of TNP-470 on cell proliferation and urokinase-type plasminogen activator and its inhibitor in human lung cancer cell lines.
    Ishikawa H; Satoh H; Kamma H; Naito T; Ohtsuka M; Ogata T; Hasegawa S
    J Exp Ther Oncol; 1996 Nov; 1(6):390-6. PubMed ID: 9414430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.